Abstract
DMPEA was injected into test rats to determine the pathways of its metabolism and to identify the resultant metabolites and their effects. The substance was absorbed into the liver, spleen, lungs, heart, and brain (minute amounts), and the course of its metabolism and the behavior of its metabolites were followed successfully. By administering the substance and its metabolites to test groups of schizophrenics and normal subjects, it may be possible to determine whether any block in the metabolism of this substance exists in schizophrenic patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
